Intuitive obtained FDA clearance for cardiovascular procedures in January. Outside of a renewed push into cardiovascular ...

Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it. Moreover, Medtronic is working to ...

Intuitive Surgical has delivered a 43.1% gain over the past three years, even as the stock has been weaker more recently.

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Tesla Inc’s TSLA Optimus is built around the biggest ambition in robotics: a general-purpose humanoid that can handle a wide ...

Intuitive Surgical’s da Vinci platform has turned robotic surgery from moonshot to default option. Now, the company is racing rivals with new systems, instruments, and data-driven tools. For years, ...

Intuitive Surgical stock remains a key name in the fast?growing robotic surgery market, and the company’s latest quarterly ...

At first glance, Gilead Sciences, Inc. (NASDAQ:GILD) and Intuitive Surgical, Inc. (NASDAQ:ISRG) don’t make for the most obvious comparison. One sells medicines led by a massive HIV franchise, while ...

Intuitive Surgical has shed a third of its value while its robotic surgery peers barely flinched, and Wall Street's most bullish analyst sees an outcome that would leave anyone who sold near the ...

At the end of the third quarter of 2025, Intuitive Surgical had placed 10,763 of its da Vinci surgical robot systems into service. That was up from 9,539 in the same quarter of 2024, a 13% increase.

Intuitive Surgical's (NASDAQ: ISRG) commanding Q2 2025 performance and the successful rollout of the da Vinci 5 have clearly positioned the company as a significant winner, while intensifying pressure ...

There is absolutely nothing wrong with Intuitive Surgical's business. In fact, the da Vinci surgical robot is industry-leading technology. And it is still selling well, with 427 new systems put in ...